%1

McKinsey & Co. is beefing up its ethics department after a series of high-profile controversies, including helping Purdue Pharma LP “turbocharge” opioid sales, Bloomberg News reported. The management consulting giant is hiring for a newly created position with its global “ethics allegations management team.” The “specialist” will be responsible for “intake and triage of matters” that could present a risk to the firm. McKinsey is also looking to replace its ethics director, a position that helps “ensure we uphold a distinctive culture of integrity and ethical behavior across our firm,” according to the job description, with a salary that ranges from US$235,000 to $314,000. “We are continually improving these processes and capabilities, which includes these ethics roles,” said Neil Grace, a McKinsey spokesperson. The company has more than more than quintupled internal risk, legal, ethics and compliance staff over the last eight years, he said. A lack of oversight at McKinsey has previously resulted in some well-publicized unsavory entanglements. The consulting firm has paid out $641 million to resolve ongoing lawsuits over its opioid work. Its South African branch has been ensnared in a corruption scandal and the company received sharp criticism for moving too slowly to cut ties with Russia after its invasion of Ukraine.

Gerard R. Vetter has been appointed by Attorney General Merrick B. Garland as the Acting U.S. Trustee for Maryland, South Carolina, Virginia, and West Virginia and for the District of Columbia (Region 4) effective July 1, the Executive Office for U.S. Trustees announced yesterday. Vetter replaces John P. Fitzgerald III, who is retiring after 43 years of dedicated service to the department, including the last four years as the Acting U.S. Trustee in Region 4. Under 28 U.S.C. § 585(a), the Attorney General may fill U.S. Trustee vacancies by appointing an Acting U.S. Trustee.